Journey Medical Corp Contracts & Agreements
34 Contracts & Agreements
- Business Finance (19 contracts)
- Business Operations (4)
- Human Resources (4)
- Intellectual Property (5)
- Uncategorized (2)
- Amendment to the Journey Medical Corporation 2015 Stock Incentive Plan (Filed With SEC on June 25, 2024)
- Credit Agreement, dated as of December 27, 2023, between Journey Medical Corporation with SWK Funding LLC (Filed With SEC on March 29, 2024)
- Second Amended and Restated License Agreement, dated as of August 31, 2023, between Journey Medical Corporation and Maruho Co., Ltd (Filed With SEC on November 13, 2023)
- License Agreement, dated as of August 31, 2023, between Journey Medical Corporation and Maruho Co., Ltd (Filed With SEC on November 13, 2023)
- Fifth Amendment to Loan and Security Agreement, dated as of May 16, 2023, by and among East West Bank, Journey Medical Corporation and JG Pharma, Inc (Filed With SEC on August 10, 2023)
- Journey Medical Corporation 2023 Employee Stock Purchase Plan (Filed With SEC on June 23, 2023)
- Form of Journey Medical Corporation 2015 Stock Plan Restricted Stock Unit Award Agreement (Filed With SEC on July 22, 2022)
- Amendment to the Journey Medical Corporation 2015 Stock Plan (Filed With SEC on June 21, 2022)
- Third Amendment to Loan and Security Agreement, entered into by and between Journey Medical Corporation and East West Bank, dated January 12, 2022 (Filed With SEC on May 10, 2022)
- Second Amendment to Loan and Security Agreement, entered into by and between Journey Medical Corporation and East West Bank, dated November 4, 2021 (Filed With SEC on May 10, 2022)
- First Amendment to Loan and Security Agreement, entered into by and between Journey Medical Corporation and East West Bank, dated March 31, 2021 (Filed With SEC on May 10, 2022)
- Shared Services Agreement with Fortress Biotech Inc., dated as of November 12, 2021 (Filed With SEC on March 28, 2022)
- Description of Securities of Journey Medical Corporation (Filed With SEC on March 28, 2022)
- Asset Purchase Agreement between VYNE Therapeutics Inc. and Journey Medical Corporation, dated as of January 12, 2022 (Filed With SEC on January 13, 2022)
- Underwriting Agreement, dated November 11, 2021, between Journey Medical Corporation and B. Riley Securities, as representative of the underwriters named therein (Filed With SEC on November 12, 2021)
- Form of Underwriting Agreement (Filed With SEC on November 8, 2021)
- Form of Indemnification Agreement between Journey Medical Corporation and each director (Filed With SEC on October 22, 2021)
- First Amendment to the License and Supply Agreement for Targadox, entered into by and between Journey Medical Corporation and Blu Caribe Inc., dated as of August 26, 2015 (Filed With SEC on October 22, 2021)
- Journey Medical Corporation 2015 Stock Plan (Filed With SEC on October 22, 2021)
- Executive Employment Agreement with Claude Maraoui, dated September 22, 2014 (Filed With SEC on October 22, 2021)
- Executive Employment Agreement with Ernie De Paolantonio (Filed With SEC on October 22, 2021)
- Non-Employee Director Compensation Plan (Filed With SEC on October 22, 2021)
- Loan and Security Agreement, entered into by and between Journey Medical Corporation and East West Bank, dated March 31, 2021 (Filed With SEC on October 22, 2021)
- Asset Purchase Agreement for Qbrexza, entered into by and between Journey Medical Corporation and Dermira, Inc., a subsidiary of Eli Lilly and Company, dated as of March 31, 2021 (Filed With SEC on October 22, 2021)
- License and Supply Agreement for Accutane, entered into by and between Journey Medical Corporation and Dr. Reddys Laboratories Ltd., dated as of July 29, 2020 (Filed With SEC on October 22, 2021)
- License and Supply Agreement for Targadox, entered into by and between Journey Medical Corporation and Blu Caribe Inc., dated as of March 10, 2015 (Filed With SEC on October 22, 2021)
- Form of Common Stock Certificate (Filed With SEC on October 22, 2021)
- Asset Purchase Agreement for Exelderm, entered into by and between Journey Medical Corporation and Sun Pharmaceutical Industries, Inc., dated as of August 31, 2018 (Filed With SEC on October 22, 2021)
- Amendment 1 to the Asset Purchase Agreement for Exelderm, entered into by and between Journey Medical Corporation and Sun Pharmaceutical Industries, Inc., dated as of September 5,... (Filed With SEC on October 22, 2021)
- Asset Purchase Agreement for Ximino, entered into by and between Journey Medical Corporation and Sun Pharmaceutical Industries, Inc., dated as of July 22, 2019 (Filed With SEC on October 22, 2021)
- Asset Purchase Agreement for the Anti-itch Product, entered into by and between Journey Medical Corporation and Sun Pharmaceutical Industries, Inc., dated as of December 18, 2020 (Filed With SEC on October 22, 2021)
- License, Collaboration, and Assignment Agreement for DFD-29, entered into by and between Journey Medical Corporation and Dr. Reddys Laboratories Ltd., dated as of June 29, 2021 (Filed With SEC on October 22, 2021)
- Form of Shared Services Agreement with Fortress Biotech, Inc (Filed With SEC on October 22, 2021)
- Fortress Promissory Note, dated as of June 6, 2015 (Filed With SEC on October 22, 2021)
